Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05981131 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Mar 11, 2025, no change to tracked fieldsv5-v6
  2. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 9 to confirmed 6 · Site details revisedv4 Show 2 more changesShow less
    • Enrollment target: estimated 9 to confirmed 6
    • Site details revised
  3. Start date changed from estimate of Aug 14, 2023 to Aug 17, 2023v3
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1v2 Show 1 more changeShow less
    • Study sites: 0 to 1
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ImmunityBio, Inc.
33 trials monitored
See 2 trials at risk
Bladder Cancer
1,022 trials monitored
See 71 trials at risk
The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.
Trial Details
NCT Number NCT05981131
Lead Sponsor ImmunityBio, Inc.
Conditions Non Muscle Invasive Bladder Cancer
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov